CD80 anticorps
Aperçu rapide pour CD80 anticorps (ABIN6297276)
Antigène
Voir toutes CD80 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- Mouse anti-Human CD80 Antibody / B7-1 [Sodium Azide Free]
-
Specificité
- Cytoplasmic, membranous
-
Purification
- Recombinant human protein used as the immunogen for the CD80 antibody.
-
Immunogène
- Recombinant human protein used as the immunogen for the CD80 antibody.
-
-
-
-
Indications d'application
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 1-2 μg/mL,ELISA (protein): order BSA free formulation for coating -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- CD80
-
Autre désignation
- T-lymphocyte activation antigen CD80
-
Sujet
-
Target Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31 % overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.
Gene Symbol: CD80///CD28LG///CD28LG1///LAB7
-
ID gène
- 941
-
UniProt
- P33681
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Antigène
-